BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up
Merck to Buy Rights to Chinese Cancer Drug for up to $3.3B
PRIVACY ALERT: Summit Pathology Under Investigation for Data Breach of Over 1.8 Million Patient Records
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
For the 4th Time, Summit Medical Staffing Makes the Inc. 5000, at No. 126 in 2024
US stocks gold digging | Delayed increase in oil production boosts oil prices! Oil and gas pipeline operator TRGP has surged nearly double in a year; outstanding performance boosts stock price! Media giant Fox Corporation hits nearly a 5-year high.
Potash production may be reduced? Belarusian President plans to raise the price of potash, fertilizer giant Nutrien hits a new high since August; pet product retailer Chewy joins the S&P MidCap 400 index, surging over 6% overnight.
Why Summit Therapeutics Stock Was a Winner Today
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
This Tencent Music Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
JMP Securities Initiates Summit Therapeutics(SMMT.US) With Buy Rating, Announces Target Price $32
JMP Securities Initiates Coverage On Summit Therapeutics With Market Outperform Rating, Announces Price Target of $32
Stifel Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $40
Summit Therapeutics Analyst Ratings
US Stock Golden | Surged 240% within the year! The social platform Reddit soared over 40% after its performance, hitting a historical high; multiple bullish factors are stimulating! The US student loan giant SoFi surged over 40% in October.
1.4 billion acquisition finalized! Pharmaceutical giant abbvie acquires Alzheimer's drug company Aliada, hitting a new high after earnings last night.
H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Cuts Target Price to $44
Express News | Summit Therapeutics PLC : H.c. Wainwright Cuts Target Price to $44 From $45
Decoding Summit Therapeutics Inc (SMMT): A Strategic SWOT Insight
Summit Therapeutics Inc (SMMT) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
Summit Therapeutics Inc. (SMMT) Q3 2024 Earnings Call Transcript Summary
Summit Therapeutics | 10-Q: Q3 2024 Earnings Report